We are live on ! Find out more
FEED

ENVUE MEDICAL INC NEW
FEED

Delisted

FEED was delisted on the 15th of September, 2026.

Back to rankings

9 hedge funds and large institutions have $679K invested in ENVUE MEDICAL INC NEW in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 6 → 9 (+3)

0.09% more ownership

Funds ownership: 5.17% → 5.27% (+0.09%)

25% less capital invested

Capital invested by funds: $906K → $679K (-$227K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.9K
2
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$15.6K
3
UBS Group
UBS Group
Switzerland
+$15.6K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$62.6K

FEED Hedge Fund Activity: Q3 2022 in Review

9 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q3 2022, worth a combined $679K — down 25% from $906K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new FEED positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $46.9K. The largest seller was Renaissance Technologies, cutting an estimated $62.6K.

  • 9 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q3 2022, up from 6 in Q2 2022.
  • Funds reported $679K of ENVUE MEDICAL INC NEW stock for Q3 2022, down 25% quarter-over-quarter.
  • 3 funds opened new ENVUE MEDICAL INC NEW positions in Q3 2022 and 0 closed out, a net change of +3 holders.
  • The largest ENVUE MEDICAL INC NEW buyer in Q3 2022 was Susquehanna International Group, an estimated $46.9K added.
  • The largest ENVUE MEDICAL INC NEW seller in Q3 2022 was Renaissance Technologies, an estimated $62.6K sold.

Based on aggregated 13F filings for Q3 2022.